(2024). Study of Serum Omentin-1 and IL-6 in Patients with Obesity, Hypertension and Hypertensive Nephropathy. test, 95(1), 1686-1696. doi: 10.21608/ejhm.2024.352946
. "Study of Serum Omentin-1 and IL-6 in Patients with Obesity, Hypertension and Hypertensive Nephropathy". test, 95, 1, 2024, 1686-1696. doi: 10.21608/ejhm.2024.352946
(2024). 'Study of Serum Omentin-1 and IL-6 in Patients with Obesity, Hypertension and Hypertensive Nephropathy', test, 95(1), pp. 1686-1696. doi: 10.21608/ejhm.2024.352946
Study of Serum Omentin-1 and IL-6 in Patients with Obesity, Hypertension and Hypertensive Nephropathy. test, 2024; 95(1): 1686-1696. doi: 10.21608/ejhm.2024.352946